Related Experiment Video

Updated: Jun 28, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics

Jason G Newland1, Gregory L Kearns

  • 1Department of Pediatrics, University of Missouri-Kansas City, Kansas City, Missouri, USA. jnewland1@cmh.edu

Paediatric Drugs
|November 13, 2008
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) infections are a growing concern in children, causing diverse illnesses. This review covers MRSA epidemiology, pathogenesis, and treatment, emphasizing abscess drainage and antibiotic choices.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Clinical Pharmacology

Background:

  • Staphylococcus aureus is a significant pediatric pathogen causing varied illnesses, from skin infections to sepsis.
  • Antimicrobial resistance, particularly Methicillin-resistant Staphylococcus aureus (MRSA), poses a growing challenge in pediatric care.
  • MRSA infections have increased in children over the last decade, necessitating updated treatment strategies.

Purpose of the Study:

  • To review the epidemiology, pathogenesis, and current treatment options for MRSA infections in pediatric patients.
  • To highlight the critical role of abscess drainage in managing skin and soft tissue infections caused by MRSA.
  • To discuss therapeutic strategies for both non-invasive and severe invasive MRSA infections in children.

Main Methods:

  • Literature review focusing on pediatric MRSA infections.
  • Analysis of epidemiological trends and pathogenic mechanisms of MRSA.
  • Evaluation of established and emerging treatment modalities for MRSA.

Main Results:

  • Skin and soft tissue infections are the most common MRSA manifestation in children, often requiring abscess drainage.
  • Vancomycin is the primary treatment for severe invasive MRSA infections.
  • Clindamycin is indicated for MRSA toxic shock syndrome and as empiric treatment for pneumonia and musculoskeletal infections.

Conclusions:

  • Effective management of pediatric MRSA infections requires a multifaceted approach including source control and appropriate antibiotic selection.
  • Understanding MRSA epidemiology and pathogenesis is crucial for guiding treatment decisions.
  • Ongoing research into newer agents and treatment strategies is essential to combat evolving MRSA resistance patterns.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: